首页 > 最新文献

Nervenarzt最新文献

英文 中文
[Migraine or pseudomigraine, that is the question! : The HaNDL syndrome]. [偏头痛还是假性偏头痛,这是个问题!:HaNDL 综合征]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-03 DOI: 10.1007/s00115-024-01682-w
Jens Schaumberg
{"title":"[Migraine or pseudomigraine, that is the question! : The HaNDL syndrome].","authors":"Jens Schaumberg","doi":"10.1007/s00115-024-01682-w","DOIUrl":"10.1007/s00115-024-01682-w","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"938-941"},"PeriodicalIF":0.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen der Deutschen Schlaganfall-Gesellschaft (DSG). 德国中风协会通讯》(DSG)。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1007/s00115-024-01748-9
{"title":"Mitteilungen der Deutschen Schlaganfall-Gesellschaft (DSG).","authors":"","doi":"10.1007/s00115-024-01748-9","DOIUrl":"10.1007/s00115-024-01748-9","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":"95 10","pages":"974-976"},"PeriodicalIF":0.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pathogen-induced diseases of the spinal cord and adjacent structures]. [由病原体引起的脊髓及邻近结构疾病]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-12 DOI: 10.1007/s00115-024-01743-0
B Bassa, F Hahner, U Meyding-Lamadé

Pathogen-induced myelitis is an inflammatory disease of the spinal cord that can be caused by various pathogens including viruses, bacteria, fungi or parasites. The most frequent viral pathogens include herpes and enteroviruses, while bacterial myelitis can be caused by, e.g., Mycobacterium tuberculosis, Borrelia burgdorferi and Treponema pallidum. Fungi such as Candida and Aspergillus and parasites such as Toxoplasma gondii and schistosomes can also cause myelitis. The main symptom is subacute paraplegia with motor, sensory and autonomic deficits to varying degrees, often accompanied by fever and a general malaise. Following a thorough clinical examination and review of the medical history diagnostic imaging procedures, such as magnetic resonance imaging (MRI) along with cerebrospinal fluid analysis and blood tests that include antibody testing are warranted. The treatment is directed at the cause of the myelitis and mostly with anti-infective agents but for some viral pathogens no specific treatment is available and the only option is a symptomatic treatment. The prognosis is very variable and depends on the etiology and severity of the disease. A fast diagnosis and targeted treatment are crucial to achieve a good outcome.

病原体诱发的脊髓炎是一种脊髓炎症性疾病,可由病毒、细菌、真菌或寄生虫等各种病原体引起。最常见的病毒病原体包括疱疹病毒和肠道病毒,而细菌性脊髓炎可由结核分枝杆菌、布氏杆菌和苍白链球菌等引起。念珠菌和曲霉菌等真菌以及弓形虫和血吸虫等寄生虫也可引起脊髓炎。主要症状是亚急性截瘫,伴有不同程度的运动、感觉和自主神经功能障碍,常伴有发热和全身不适。在进行全面的临床检查和病史回顾后,需要进行诊断性影像学检查,如磁共振成像(MRI)、脑脊液分析和包括抗体检测在内的血液检测。治疗主要针对脊髓炎的病因,大多使用抗感染药物,但对于某些病毒性病原体,目前尚无特效治疗方法,唯一的选择是对症治疗。预后很不稳定,取决于病因和疾病的严重程度。快速诊断和有针对性的治疗是取得良好疗效的关键。
{"title":"[Pathogen-induced diseases of the spinal cord and adjacent structures].","authors":"B Bassa, F Hahner, U Meyding-Lamadé","doi":"10.1007/s00115-024-01743-0","DOIUrl":"10.1007/s00115-024-01743-0","url":null,"abstract":"<p><p>Pathogen-induced myelitis is an inflammatory disease of the spinal cord that can be caused by various pathogens including viruses, bacteria, fungi or parasites. The most frequent viral pathogens include herpes and enteroviruses, while bacterial myelitis can be caused by, e.g., Mycobacterium tuberculosis, Borrelia burgdorferi and Treponema pallidum. Fungi such as Candida and Aspergillus and parasites such as Toxoplasma gondii and schistosomes can also cause myelitis. The main symptom is subacute paraplegia with motor, sensory and autonomic deficits to varying degrees, often accompanied by fever and a general malaise. Following a thorough clinical examination and review of the medical history diagnostic imaging procedures, such as magnetic resonance imaging (MRI) along with cerebrospinal fluid analysis and blood tests that include antibody testing are warranted. The treatment is directed at the cause of the myelitis and mostly with anti-infective agents but for some viral pathogens no specific treatment is available and the only option is a symptomatic treatment. The prognosis is very variable and depends on the etiology and severity of the disease. A fast diagnosis and targeted treatment are crucial to achieve a good outcome.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"948-956"},"PeriodicalIF":0.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives]. [周围神经免疫疾病--神经病理学见解和临床视角]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 Epub Date: 2024-09-20 DOI: 10.1007/s00115-024-01725-2
Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, Tobias Ruck, Nikolas Ruffer, Frauke Stascheit, Werner Stenzel

This article deals with peripheral neuroimmunological diseases and briefly outlines the currently most important aspects and treatment developments. Idiopathic inflammatory myopathies have different mechanisms of development, manifestations and prognoses. New classification systems and more specific treatment concepts have been developed. The IIMs include different subgroups. These entities can have specific autoantibodies. Diagnostically, a muscle biopsy is generally desirable for a precise diagnosis and is essential in unclear cases. Primary systemic vasculitides can be divided into different groups based on the predominant pattern of involvement, while secondary vasculitides and single organ vasculitides are also differentiated. Vasculitic myopathy cannot be equated with myositis and a reliable distinction is currently only possible by a muscle biopsy. Treatment concepts should be developed on an interdisciplinary basis. Chronic inflammatory demyelinating polyneuropathy is the most frequent immune-mediated neuropathy and is characterized by a predominant demyelination of the motor and sensory nerves. The disease course runs in phases or is progressive and leads to significant disability and reduction in quality of life, despite current standard treatment. Novel treatment approaches are currently undergoing clinical trials. Myasthenia gravis, with the leading symptom of exercise-induced muscle weakness, is caused by autoantibodies against structures of the neuromuscular endplate. Autoantibody testing is the most important pillar in the diagnosis and is now also increasingly guiding treatment decisions. Overall, peripheral neuroimmunological diseases represent a heterogeneous group. Increasing knowledge of the pathophysiology is the key to numerous developments in diagnostics and treatment, which could lead to far-reaching practical changes in the future.

本文论述了周围神经免疫疾病,并简要概述了当前最重要的方面和治疗进展。特发性炎症性肌病的发病机制、表现和预后各不相同。新的分类系统和更具体的治疗概念已经形成。特发性炎症性肌病包括不同的亚组。这些疾病都有特定的自身抗体。在诊断方面,肌肉活检通常是精确诊断的理想方法,对于不明确的病例来说,肌肉活检是必不可少的。原发性系统性血管炎可根据主要受累模式分为不同的组别,而继发性血管炎和单器官血管炎也有区别。血管炎性肌病不能等同于肌炎,目前只有通过肌肉活检才能进行可靠的区分。应在跨学科的基础上制定治疗方案。慢性炎症性脱髓鞘性多发性神经病是最常见的免疫介导型神经病,其特点是运动神经和感觉神经脱髓鞘为主。该病的病程呈阶段性或进行性发展,会导致严重的残疾和生活质量下降,尽管目前采用了标准治疗方法。新的治疗方法目前正在进行临床试验。肌无力症的主要症状是运动引起的肌无力,是由针对神经肌肉终板结构的自身抗体引起的。自身抗体检测是诊断中最重要的支柱,现在也越来越多地指导治疗决策。总体而言,外周神经免疫疾病是一个异质性的群体。对病理生理学的进一步了解是诊断和治疗领域取得众多进展的关键,这可能会在未来带来意义深远的实际变化。
{"title":"[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives].","authors":"Sarah Hoffmann, Marie-Therese Holzer, Corinna Preuße, Tobias Ruck, Nikolas Ruffer, Frauke Stascheit, Werner Stenzel","doi":"10.1007/s00115-024-01725-2","DOIUrl":"10.1007/s00115-024-01725-2","url":null,"abstract":"<p><p>This article deals with peripheral neuroimmunological diseases and briefly outlines the currently most important aspects and treatment developments. Idiopathic inflammatory myopathies have different mechanisms of development, manifestations and prognoses. New classification systems and more specific treatment concepts have been developed. The IIMs include different subgroups. These entities can have specific autoantibodies. Diagnostically, a muscle biopsy is generally desirable for a precise diagnosis and is essential in unclear cases. Primary systemic vasculitides can be divided into different groups based on the predominant pattern of involvement, while secondary vasculitides and single organ vasculitides are also differentiated. Vasculitic myopathy cannot be equated with myositis and a reliable distinction is currently only possible by a muscle biopsy. Treatment concepts should be developed on an interdisciplinary basis. Chronic inflammatory demyelinating polyneuropathy is the most frequent immune-mediated neuropathy and is characterized by a predominant demyelination of the motor and sensory nerves. The disease course runs in phases or is progressive and leads to significant disability and reduction in quality of life, despite current standard treatment. Novel treatment approaches are currently undergoing clinical trials. Myasthenia gravis, with the leading symptom of exercise-induced muscle weakness, is caused by autoantibodies against structures of the neuromuscular endplate. Autoantibody testing is the most important pillar in the diagnosis and is now also increasingly guiding treatment decisions. Overall, peripheral neuroimmunological diseases represent a heterogeneous group. Increasing knowledge of the pathophysiology is the key to numerous developments in diagnostics and treatment, which could lead to far-reaching practical changes in the future.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"920-931"},"PeriodicalIF":0.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Immunological foundations of neurological diseases]. [神经系统疾病的免疫学基础]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-02 DOI: 10.1007/s00115-024-01696-4
Hansjörg Schild, Tobias Bopp

Background: Neurodegenerative diseases represent an increasing challenge in ageing societies, as only limited treatment options are currently available.

Objective: New research methods and interdisciplinary interaction of different disciplines have changed the way neurological disorders are viewed and paved the way for the comparatively new field of neuroimmunology, which was established in the early 1980s. Starting from neurological autoimmune diseases, such as multiple sclerosis, knowledge about the involvement of immunological processes in other contexts, such as stroke or traumatic brain injury, has been significantly expanded in recent years.

Material and methods: This review article provides an overview of the role of the immune system and the resulting potential for novel treatment approaches.

Results: The immune system plays a central role in fighting infections but is also able to react to the body's own signals under sterile conditions and cause inflammation and subsequent adaptive immune responses through the release of immune mediators and the recruitment and differentiation of certain immune cell types. This can be beneficial in initiating healing processes; however, chronic inflammatory conditions usually have destructive consequences for the tissue and the organism and must be interrupted.

Conclusion: It is now known that different cells of the immune system play an important role in neurological diseases. Regulatory mechanisms, which are mediated by regulatory T cells or Th2 cells, are usually associated with a good prognosis, whereas inflammatory processes and polarization towards Th1 or Th17 have a destructive character. Novel immunomodulators, which are also increasingly being used in cancer treatment, can now be used in a tissue-specific manner and therefore offer great potential for use in neurological diseases.

背景:神经退行性疾病是老龄化社会面临的一个日益严峻的挑战,因为目前可供选择的治疗方法非常有限:新的研究方法和不同学科间的互动改变了人们对神经系统疾病的看法,并为 20 世纪 80 年代初建立的相对较新的神经免疫学领域铺平了道路。从神经系统自身免疫性疾病(如多发性硬化症)开始,近年来有关免疫过程参与其他情况(如中风或脑外伤)的知识得到了显著扩展:这篇综述文章概述了免疫系统的作用以及由此产生的新型治疗方法的潜力:免疫系统在抗感染方面发挥着核心作用,但在无菌条件下也能对人体自身的信号做出反应,并通过释放免疫介质以及招募和分化某些免疫细胞类型来引起炎症和随后的适应性免疫反应。这对启动愈合过程是有益的;但慢性炎症通常会对组织和机体造成破坏性后果,必须加以阻断:现在人们已经知道,免疫系统的不同细胞在神经系统疾病中扮演着重要角色。由调节性 T 细胞或 Th2 细胞介导的调节机制通常预后良好,而炎症过程和 Th1 或 Th17 极化则具有破坏性。新型免疫调节剂也越来越多地用于癌症治疗,现在可以以组织特异性的方式使用,因此在神经系统疾病方面具有巨大的应用潜力。
{"title":"[Immunological foundations of neurological diseases].","authors":"Hansjörg Schild, Tobias Bopp","doi":"10.1007/s00115-024-01696-4","DOIUrl":"10.1007/s00115-024-01696-4","url":null,"abstract":"<p><strong>Background: </strong>Neurodegenerative diseases represent an increasing challenge in ageing societies, as only limited treatment options are currently available.</p><p><strong>Objective: </strong>New research methods and interdisciplinary interaction of different disciplines have changed the way neurological disorders are viewed and paved the way for the comparatively new field of neuroimmunology, which was established in the early 1980s. Starting from neurological autoimmune diseases, such as multiple sclerosis, knowledge about the involvement of immunological processes in other contexts, such as stroke or traumatic brain injury, has been significantly expanded in recent years.</p><p><strong>Material and methods: </strong>This review article provides an overview of the role of the immune system and the resulting potential for novel treatment approaches.</p><p><strong>Results: </strong>The immune system plays a central role in fighting infections but is also able to react to the body's own signals under sterile conditions and cause inflammation and subsequent adaptive immune responses through the release of immune mediators and the recruitment and differentiation of certain immune cell types. This can be beneficial in initiating healing processes; however, chronic inflammatory conditions usually have destructive consequences for the tissue and the organism and must be interrupted.</p><p><strong>Conclusion: </strong>It is now known that different cells of the immune system play an important role in neurological diseases. Regulatory mechanisms, which are mediated by regulatory T cells or Th2 cells, are usually associated with a good prognosis, whereas inflammatory processes and polarization towards Th1 or Th17 have a destructive character. Novel immunomodulators, which are also increasingly being used in cancer treatment, can now be used in a tissue-specific manner and therefore offer great potential for use in neurological diseases.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"894-908"},"PeriodicalIF":0.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mentally ill citizens as victims of violation of physical integrity and extermination under the NS regime based on the example of a German city]. [根据德国城市的例子,精神病公民是新国家政权侵犯人身安全和灭绝行为的受害者]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-26 DOI: 10.1007/s00115-024-01745-y
Beatrice Rose, Jörg-Stefan Schulz, Eckhard Sundermann, Paraskevi Mavrogiorgou, Georg Juckel

Background: Even 90 years after the National Socialist seizure of power and the beginning of the darkest chapter of German psychiatric history, examination of the medical historical past retains great relevance as an ongoing medical responsibility. The interventions in the lives of mentally ill people by the National Socialist regime are a firmly established part of medical historical research; however, little is known about how specific regions proceeded with affected citizens.

Objective: The aim of this study was therefore to identify transfer routes of the "euthanasia" transports and places of death of the victims from Bochum as well as their patient characteristics.

Materials and methods: During the timeframe studied, inpatient care for mentally ill patients from the Westphalia region was provided in seven provincial institutions. There was no psychiatric clinic in Bochum at the time, so patients were distributed among these institutions. The investigation was based on the transfer lists of the Westphalian provincial institutions to the killing sites.

Results and conclusion: A total of 366 Bochum citizens affected by "euthanasia" transfers were identified. The transport lists were verified by admission and departure books, death lists, and patient files. The hereditary health files of the city archive were used to examine the relocated Bochum patients to determine whether they were victims of forced sterilization.

背景:即使在国家社会主义夺取政权和德国精神病史上最黑暗篇章开始的 90 年之后,作为一项持续的医学责任,对医学历史的研究仍具有重要意义。国家社会主义政权对精神病患者生活的干预是医学史研究的一个既定部分;然而,人们对特定地区如何处理受影响的公民却知之甚少:因此,本研究旨在确定 "安乐死 "的转运路线、波鸿受害者的死亡地点及其患者特征:在研究期间,威斯特伐利亚地区的精神病患者在七个省级机构接受住院治疗。当时波鸿还没有精神病诊所,因此病人分布在这些机构中。调查以威斯特法伦省精神病院向杀人现场的转院名单为依据:结果和结论:共确认了 366 名受 "安乐死 "转院影响的波鸿市民。转院名单通过入院和出院记录、死亡名单和病人档案进行了核实。市档案馆的遗传健康档案被用来检查被转移的波鸿病人,以确定他们是否是强制绝育的受害者。
{"title":"[Mentally ill citizens as victims of violation of physical integrity and extermination under the NS regime based on the example of a German city].","authors":"Beatrice Rose, Jörg-Stefan Schulz, Eckhard Sundermann, Paraskevi Mavrogiorgou, Georg Juckel","doi":"10.1007/s00115-024-01745-y","DOIUrl":"https://doi.org/10.1007/s00115-024-01745-y","url":null,"abstract":"<p><strong>Background: </strong>Even 90 years after the National Socialist seizure of power and the beginning of the darkest chapter of German psychiatric history, examination of the medical historical past retains great relevance as an ongoing medical responsibility. The interventions in the lives of mentally ill people by the National Socialist regime are a firmly established part of medical historical research; however, little is known about how specific regions proceeded with affected citizens.</p><p><strong>Objective: </strong>The aim of this study was therefore to identify transfer routes of the \"euthanasia\" transports and places of death of the victims from Bochum as well as their patient characteristics.</p><p><strong>Materials and methods: </strong>During the timeframe studied, inpatient care for mentally ill patients from the Westphalia region was provided in seven provincial institutions. There was no psychiatric clinic in Bochum at the time, so patients were distributed among these institutions. The investigation was based on the transfer lists of the Westphalian provincial institutions to the killing sites.</p><p><strong>Results and conclusion: </strong>A total of 366 Bochum citizens affected by \"euthanasia\" transfers were identified. The transport lists were verified by admission and departure books, death lists, and patient files. The hereditary health files of the city archive were used to examine the relocated Bochum patients to determine whether they were victims of forced sterilization.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The relevance of pharmacogenetic testing in forensics]. [药物基因检测在法医学中的相关性]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-26 DOI: 10.1007/s00115-024-01746-x
Helmar Weiß, Erikas Vasiliauskas, Volkmar Blendl, Aleh Maksimiuk
{"title":"[The relevance of pharmacogenetic testing in forensics].","authors":"Helmar Weiß, Erikas Vasiliauskas, Volkmar Blendl, Aleh Maksimiuk","doi":"10.1007/s00115-024-01746-x","DOIUrl":"https://doi.org/10.1007/s00115-024-01746-x","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Genetic diagnostics of mental health disorders in adulthood]. [成年期精神疾病的基因诊断]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-24 DOI: 10.1007/s00115-024-01737-y
Laura L Kilarski, Isabelle Claus, Elisabeth B Binder, Franziska Degenhardt, Katharina Domschke, Andreas J Forstner, Hans J Grabe, Urs Heilbronner, Daniel Müller, Markus M Nöthen, Franziska Radtke, Marcella Rietschel, Thomas G Schulze, Fabian Streit, Ludger Tebartz van Elst, Oliver Tüscher, Jürgen Deckert, Eva C Schulte

This review article provides insights into the role of genetic diagnostics in adult mental health disorders. The importance of genetic factors in the development of mental illnesses, from rare genetic syndromes to common complex genetic disorders, is described. Current clinical characteristics that may warrant a genetic diagnostic work-up are highlighted, including intellectual disability, autism spectrum disorders and severe psychiatric conditions with specific comorbidities, such as organ malformations or epilepsy. The review discusses when genetic diagnostics are recommended according to current guidelines as well as situations where they might be considered even in the absence of explicit guideline recommendations. This is followed by an overview of the procedures and the currently used diagnostic methods. Current limitations and possible developments in the field of genetic diagnostics in psychiatry are discussed, including the fact that, for many mental health conditions, genetic testing is not yet part of standard clinical practice; however, in summary genetic causes should be considered more frequently in certain clinical constellations, and genetic diagnostics and counselling should be offered where appropriate.

这篇综述文章深入探讨了基因诊断在成人精神疾病中的作用。从罕见的遗传综合征到常见的复杂遗传性疾病,文章阐述了遗传因素在精神疾病发病过程中的重要性。重点介绍了目前可能需要进行基因诊断工作的临床特征,包括智力障碍、自闭症谱系障碍和严重的精神疾病,以及器官畸形或癫痫等特殊并发症。综述讨论了根据现行指南建议何时进行基因诊断,以及在没有明确指南建议的情况下可以考虑进行基因诊断的情况。随后概述了相关程序和目前使用的诊断方法。此外,还讨论了精神病学基因诊断领域目前存在的局限性和可能的发展,包括对于许多精神疾病而言,基因检测尚未成为标准临床实践的一部分这一事实;但总而言之,在某些临床组合中,应更多地考虑遗传原因,并在适当的情况下提供基因诊断和咨询。
{"title":"[Genetic diagnostics of mental health disorders in adulthood].","authors":"Laura L Kilarski, Isabelle Claus, Elisabeth B Binder, Franziska Degenhardt, Katharina Domschke, Andreas J Forstner, Hans J Grabe, Urs Heilbronner, Daniel Müller, Markus M Nöthen, Franziska Radtke, Marcella Rietschel, Thomas G Schulze, Fabian Streit, Ludger Tebartz van Elst, Oliver Tüscher, Jürgen Deckert, Eva C Schulte","doi":"10.1007/s00115-024-01737-y","DOIUrl":"https://doi.org/10.1007/s00115-024-01737-y","url":null,"abstract":"<p><p>This review article provides insights into the role of genetic diagnostics in adult mental health disorders. The importance of genetic factors in the development of mental illnesses, from rare genetic syndromes to common complex genetic disorders, is described. Current clinical characteristics that may warrant a genetic diagnostic work-up are highlighted, including intellectual disability, autism spectrum disorders and severe psychiatric conditions with specific comorbidities, such as organ malformations or epilepsy. The review discusses when genetic diagnostics are recommended according to current guidelines as well as situations where they might be considered even in the absence of explicit guideline recommendations. This is followed by an overview of the procedures and the currently used diagnostic methods. Current limitations and possible developments in the field of genetic diagnostics in psychiatry are discussed, including the fact that, for many mental health conditions, genetic testing is not yet part of standard clinical practice; however, in summary genetic causes should be considered more frequently in certain clinical constellations, and genetic diagnostics and counselling should be offered where appropriate.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142308928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Life style drug laughing gas (nitrous oxide, N2O) and the dependency criteria according to ICD-10]. [生活方式药物笑气(一氧化二氮,N2O)和 ICD-10 的依赖标准]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-23 DOI: 10.1007/s00115-024-01736-z
Dominik Diesing, Peter Neu

Objective: The increasing popularity of nitrous oxide (N2O) as a recreational drug raises questions about its potential for dependency. This narrative review examines the dependency risk of N2O using the ICD-10 criteria for substance use disorders and evaluates the current literature.

Material and methods: A comprehensive literature search until April 2024 was conducted to identify publications addressing N2O consumption in the context of dependency criteria. The results were analyzed based on the ICD-10 criteria.

Results: Studies showed mixed results regarding craving and loss of control among N2O users. There is evidence of neglect of other interests and potential tolerance development, while data on withdrawal symptoms are limited. Persistent consumption despite harmful consequences has been described but objective diagnostic methods to determine consumption intensity are lacking.

Discussion: The data on the dependency potential of N2O are inconsistent. The discussion on its classification as an addictive substance remains controversial; however, the clinical indications suggest a possible risk of dependency, especially with excessive consumption.

Conclusion: Nitrous oxide is currently primarily regarded as a substance of abuse with the potential to foster psychological dependence, manifesting particularly through loss of control and neglect; however, the criteria for physical dependence, such as the occurrence of withdrawal syndromes and the development of tolerance, have not yet been convincingly documented. Further research is needed to better understand the dependency potential of N2O and develop appropriate preventive and therapeutic measures.

目的:一氧化二氮(N2O)作为一种娱乐性药物越来越受到人们的欢迎,这引发了人们对其潜在依赖性的质疑。这篇叙述性综述采用 ICD-10 物质使用障碍标准研究了一氧化二氮的依赖性风险,并对现有文献进行了评估:我们对截至 2024 年 4 月的文献进行了全面检索,以确定在依赖性标准方面涉及 N2O 消费的出版物。根据 ICD-10 标准对结果进行了分析:研究结果显示,N2O 使用者对 N2O 的渴望和失控程度不一。有证据表明,N2O 使用者会忽视其他兴趣,并可能产生耐受性,而有关戒断症状的数据则十分有限。尽管存在有害后果,但仍有持续消费的描述,但缺乏确定消费强度的客观诊断方法:有关一氧化二氮潜在依赖性的数据并不一致。关于将一氧化二氮归类为成瘾物质的讨论仍存在争议;不过,临床迹象表明,一氧化二氮可能存在依赖性风险,尤其是在过量消费的情况下:一氧化二氮目前主要被视为一种滥用物质,有可能产生心理依赖,特别是通过失控和忽视表现出来;然而,生理依赖的标准,如出现戒断综合征和产生耐受性,尚未得到令人信服的证明。为了更好地了解一氧化二氮的潜在依赖性并制定适当的预防和治疗措施,需要开展进一步的研究。
{"title":"[Life style drug laughing gas (nitrous oxide, N<sub>2</sub>O) and the dependency criteria according to ICD-10].","authors":"Dominik Diesing, Peter Neu","doi":"10.1007/s00115-024-01736-z","DOIUrl":"https://doi.org/10.1007/s00115-024-01736-z","url":null,"abstract":"<p><strong>Objective: </strong>The increasing popularity of nitrous oxide (N<sub>2</sub>O) as a recreational drug raises questions about its potential for dependency. This narrative review examines the dependency risk of N<sub>2</sub>O using the ICD-10 criteria for substance use disorders and evaluates the current literature.</p><p><strong>Material and methods: </strong>A comprehensive literature search until April 2024 was conducted to identify publications addressing N<sub>2</sub>O consumption in the context of dependency criteria. The results were analyzed based on the ICD-10 criteria.</p><p><strong>Results: </strong>Studies showed mixed results regarding craving and loss of control among N<sub>2</sub>O users. There is evidence of neglect of other interests and potential tolerance development, while data on withdrawal symptoms are limited. Persistent consumption despite harmful consequences has been described but objective diagnostic methods to determine consumption intensity are lacking.</p><p><strong>Discussion: </strong>The data on the dependency potential of N<sub>2</sub>O are inconsistent. The discussion on its classification as an addictive substance remains controversial; however, the clinical indications suggest a possible risk of dependency, especially with excessive consumption.</p><p><strong>Conclusion: </strong>Nitrous oxide is currently primarily regarded as a substance of abuse with the potential to foster psychological dependence, manifesting particularly through loss of control and neglect; however, the criteria for physical dependence, such as the occurrence of withdrawal syndromes and the development of tolerance, have not yet been convincingly documented. Further research is needed to better understand the dependency potential of N<sub>2</sub>O and develop appropriate preventive and therapeutic measures.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Risk for post-injection syndrome after administration of olanzapine depot : Findings of real-world data evaluation at a psychiatric university hospital with a full-range care mandate]. [注射奥氮平后出现注射后综合征的风险较低:一家承担全方位护理任务的大学精神病医院的实际数据评估结果]。
IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2024-09-17 DOI: 10.1007/s00115-024-01733-2
Wolfgang Strube, Elias Wagner, Andreas Gartenmaier, Antje Grünemeyer, Klaus Peter Schmelzer, Alkomiet Hasan
{"title":"[Risk for post-injection syndrome after administration of olanzapine depot : Findings of real-world data evaluation at a psychiatric university hospital with a full-range care mandate].","authors":"Wolfgang Strube, Elias Wagner, Andreas Gartenmaier, Antje Grünemeyer, Klaus Peter Schmelzer, Alkomiet Hasan","doi":"10.1007/s00115-024-01733-2","DOIUrl":"10.1007/s00115-024-01733-2","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nervenarzt
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1